Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results ...

A cortical tri-culture model advances the validation process in neurodegenerative drug discovery, offering new possibilities ...

Ginkgo Bioworks introduces a protein large language model and API, developed with Google Cloud, to streamline drug discovery ...

Venture capital dollars continue to pour into companies applying artificial intelligence techniques to health care in an ...

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the ...

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with ...

SwRI and UTSA will work together to combat the growing threat antimicrobial resistance poses to global health by developing a proof-of-concept platform to potentially create a whole library of new ...

PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD) ...

Corp. (OTC PINK:CBDW) (the “Company” or “1606”) is pleased to announce it has signed a Letter of Intent to acquire a strategic stake in Adnexus Biotechnologies Inc., a pioneering company in Artificial ...

PSC-derived cells and micro-physiological systems provide significant advancements in enhancing neuronal disease models, ...

Generative AI can design never-before-seen proteins quickly and at scale, streamlining the drug design process like never ...

Boston, MA – The much-anticipated RE•WORK AI in Healthcare & Pharma Summit is set to take place on November 13-14, 2024, at ...